Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to low long-term survival rates, with only 7.2% of patients surviving beyond […]

While skin cancer can affect anyone, people with fair skin are twice as likely to develop skin cancer than those with darker skin complexions.

An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, one of the four National Cancer […]

Along with medications, dietary management is crucial for patients to reduce chemotherapy-induced symptoms like nausea and vomiting.

Brian Fricke, MD, sits down to explain cancer rehabilitation along with its purpose and benefits.

  The Mays Cancer Center at the University of Texas Health Science Center at San Antonio has ranked fourth in the nation for clinical trial enrollments among over a thousand institutions that are members of SWOG Cancer Research Network, formerly known as the Southwestern Oncology Group. SWOG is an organization supported by the National Cancer […]

Anton Fries, MD, sits down to explain cancer cancer-related lymphedema and its treatment options.

After Leonel Rodriguez was diagnosed with an aggressive, incurable form of non-Hodgkin lymphoma in 2019, he was told he only had a few months to live.

Alicia Logue, MD, sits down to explain the surgical options for colorectal cancer.